Skip to main content
David Rubinow, MD, Psychiatry, Chapel Hill, NC

David R Rubinow MD

Psychiatry•Chapel Hill, NC

Professor and Chair of Psychiatry; Professor of Medicine; Director, UNC Innovation and Health Care System Transformation; and Director, UNC Center for Women’s Mood Disorders

Join to View Full Profile

  • 101 Manning DrChapel Hill, NC 27514

  • Phone+1 919-966-8596

  • Fax+1 919-843-5515

Dr. Rubinow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Rubinow's Full ProfileAlready have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Psychiatry, 1979 - 1981
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Psychiatry, 1976 - 1979
  • Uconn School Of Medicine
    Uconn School Of MedicineClass of 1975

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2006 - 2026
  • MD State Medical License
    MD State Medical License 1980 - 2007
  • DC State Medical License
    DC State Medical License 1982 - 2006
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Safety of Estradiol Treatment in Perimenopausal Asymptomatic Women—Reply  
    David Rubinow, MD, JAMA
  • Sex Differences and the Neurobiology of Affective Disorders  
    David Rubinow, MD, Nature

Authored Content

  • Progesterone and Plasma Metabolites in Women with and in Those Without Premenstrual Dysphoric DisorderSeptember 2018
  • Progesterone and Plasma Metabolites in Women with and in Those Without Premenstrual Dysphoric DisorderSeptember 2018
  • F122. The Neuronal Stem Cell Transcriptome of Premenstrual Dysphoric DisorderApril 2018
  • S102. Pilot Double-Blind, Placebo-Controlled Clinical Trial of Transcranial Alternating Current Stimulation (tACS) for the Treatment of Major Depressive DisorderApril 2018
  • S100. Efficacy and Safety of Brexanolone IV Across Phase 2/3 Studies: A First-in-Class GABAA Receptor Positive Allosteric Modulator for Postpartum DepressionApril 2018
  • Join now to see all

Press Mentions

  • FDA Grants Breakthrough Device Designation for Non-Invasive Brain Stimulation Device to Treat Major Depressive Disorder
    FDA Grants Breakthrough Device Designation for Non-Invasive Brain Stimulation Device to Treat Major Depressive DisorderMarch 10th, 2025
  • Personalized Brain Stimulation Significantly Decreases Depression Symptoms
    Personalized Brain Stimulation Significantly Decreases Depression SymptomsAugust 27th, 2024
  • FDA Approves ZULRESSO™ (Brexanolone) Injection for Postpartum Depression Following Three Clinical Trials Led by UNC Researcher
    FDA Approves ZULRESSO™ (Brexanolone) Injection for Postpartum Depression Following Three Clinical Trials Led by UNC ResearcherMarch 20th, 2019
  • Join now to see all

Grant Support

  • Postdoctoral Training in Reproductive Mood DisordersUNIV OF NORTH CAROLINA CHAPEL HILL2012–2028
  • Stress-stimulated immune profiles and cardiometabolic risk during the menopausal transitionUNIV OF NORTH CAROLINA CHAPEL HILL2022–2025
  • Depression, Estrogen Replacement, And Cardiovascular Health In The PerimenopauseNational Institute Of Mental Health2010–2012
  • Continuous OC Treatment In PMDD: Steroid Hormone MechanismsNational Institute Of Mental Health2008–2011
  • Menstrually Related Mood Disorders Screening ProtocolNational Center For Research Resources2008
  • Sex Dimorphisms/Gonadal Steroid Effect--NeuroregulationNational Institute Of Mental Health2005
  • Reproductive Endocrine Related Mood DisordersNational Institute Of Mental Health2003–2005
  • Neuroregulation: Sexual Dimorphisms And Gonadal SteroidsNational Institute Of Mental Health2004
  • Reproductive Endocrine Related Mood Disorders--DifferentNational Institute Of Mental Health2001–2004
  • Sexual Dimorphisms &Gonadal Steroid Effects On NeuroregNational Institute Of Mental Health2001–2003
  • Sexual Dimorphisms &Gonadal Steroid Effects On Neuroregulation/NeurodevelopmentNational Institute Of Mental Health1997–2000
  • Reproductive Endocrine Related Mood Disorders--Differential SensitivityNational Institute Of Mental Health1997–2000
  • Sexual Dimorphisms &Amp;Gonadal Steroid Effects On Neuroregulation/NeurodevelopmNational Institute Of Mental Health1998
  • Psychobiology And Treatment Of Menstrually Related Mood DisordersNational Institute Of Mental Health1997
  • Psychobiology And Treatment Of Menstrually-Related Mood DisordersNational Institute Of Mental Health1996
  • Psychobiology And Treatment Of Peri-Menopausal Mood DisordersNational Institute Of Mental Health1991–1995
  • Psychobiology And Treatment Of Peri-Menopausal DisordersNational Institute Of Mental Health1990

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. David Rubinow, Dr. David Rubinow, MD, Dr. D Rubinow, Dr. David R Rubinow